SCHEMBL22097044

SCHEMBL22097044

c1ccc(-c2nc(-c3ccc4c(c3)c3ccccc3c3c4ccc4sc5ccccc5c43)nc3c2ccc2ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.36
CYP1B1 Q16678 2/20 0.36
CYP1A2 P05177 1/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ATM Q13315 1/20 0.34
WHR1 P49842 1/20 0.33
LIMK1 P53667 1/20 0.31
NQO1 P15559 1/20 0.31
NQO2 P16083 1/20 0.31
MAOA P21397 1/20 0.31
MAPT P10636 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
LMNA P02545 1/20 0.31
MAPK1 P28482 1/20 0.31
RECQL P46063 1/20 0.31
MMP14 P50281 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22096948 1.00 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2MEN1KMT2A
SCHEMBL24628284 0.93 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2MEN1KMT2A
SCHEMBL22880517 0.93 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2MEN1KMT2A
SCHEMBL22879832 0.90 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2MEN1KMT2A
SCHEMBL22258632 0.90 MEN1 (0.36) CYP1A1CYP1B1CYP1A2MEN1KMT2A
SCHEMBL22097230 0.88 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2MEN1KMT2A
SCHEMBL22097003 0.88 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2MEN1KMT2A
SCHEMBL22096958 0.88 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2MEN1KMT2A
SCHEMBL22097026 0.88 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2MEN1KMT2A
SCHEMBL22097040 0.88 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 CYP1A1 915/4885CYP1B1 1186/4885CYP1A2 1063/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 CYP1A1 915/4885CYP1B1 1186/4885CYP1A2 1063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.